DHTRF
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
DHTRF (DHTRF) - Total Assets
Latest total assets as of September 2025: $909.05 Million USD
Based on the latest financial reports, DHTRF (DHTRF) holds total assets worth $909.05 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
DHTRF - Total Assets Trend (2021–2024)
This chart illustrates how DHTRF’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
DHTRF - Asset Composition Analysis
Current Asset Composition (September 2024)
DHTRF's total assets of $909.05 Million consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $823.94 Million | 83.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how DHTRF's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DHTRF's current assets represent 0.0% of total assets in 2024, unchanged from 0.0% in 2021.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, down from 14.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 83.0% of total assets, an increase from 67.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 83.7% of total assets.
DHTRF Competitors by Total Assets
Key competitors of DHTRF based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
DHTRF - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - DHTRF generates 0.14x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - DHTRF is currently not profitable relative to its asset base.
DHTRF - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | - | - | |
| Quick Ratio | - | - | |
| Cash Ratio | - | - | |
| Working Capital | $- | - | - |
DHTRF - Advanced Valuation Insights
This section examines the relationship between DHTRF's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.49 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 18.2% |
| Total Assets | $984.87 Million |
| Market Capitalization | $76.97K USD |
Valuation Analysis
Below Book Valuation: The market values DHTRF's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: DHTRF's assets grew by 18.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for DHTRF (2021–2024)
The table below shows the annual total assets of DHTRF from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-09-30 | $984.87 Million | +18.21% |
| 2023-09-30 | $833.16 Million | +31.53% |
| 2022-09-30 | $633.42 Million | +45.05% |
| 2021-09-30 | $436.69 Million | -- |